Aurora Cannabis Acquires Safari Flower Co. for C$26.5M to Fuel Global Expansion

Key Facts

1Aurora Cannabis acquired Safari Flower Co. for C$26.5 million in a stock-and-cash deal.

2The deal includes an EU GMP certified indoor cultivation and manufacturing facility in Ontario.

3The acquisition aims to boost capacity for international medical cannabis markets including Germany, Australia, Poland, and the UK.

Aurora Cannabis Inc. officially announced on April 15, 2026, the completion of its acquisition of Safari Flower Co. for an aggregate consideration of C$26.5 million. The transaction includes a mix of stock and cash, featuring a contingent cash payment of C$2 million based on the satisfaction of specific conditions, with the final price subject to customary adjustments. The deal provides Aurora with a sophisticated EU GMP-certified indoor cultivation facility in Ontario, designed to boost production for high-growth markets like Germany, Australia, and the UK. Management indicated that securing this infrastructure is key to capturing a larger share of the global medical cannabis sector. Analysts view the move as a bullish development for Aurora's supply chain efficiency and international scaling efforts. The integration of these assets is expected to strengthen Aurora's competitive positioning in premium global markets.

6 months ago

Version History

Version 16 months ago

What changed: Updated the story to include the official announcement date of April 15, 2026, specify the C$2 million contingent cash component, and note that the aggregate consideration is subject to customary adjustments.